Copyright
©2012 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. Aug 6, 2012; 3(4): 49-61
Published online Aug 6, 2012. doi: 10.4292/wjgpt.v3.i4.49
Published online Aug 6, 2012. doi: 10.4292/wjgpt.v3.i4.49
Table 1 General indications for liver transplantation
| Acute liver failure |
| Complications of cirrhosis |
| Ascites |
| Encephalopathy |
| Synthetic dysfunction |
| Liver cancer |
| Refractory variceal hemorrhage |
| Chronic gastrointestinal blood loss due to portal hypertensive |
| gastropathy |
| Hepatopulmonary syndrome |
| Portopulmonary hypertension |
| Hepatorenal syndrome |
| Recurrent cholangitis |
| Intractable pruritus |
| Malnutrition |
| Hepatic myelopathy |
| Quality of life impairment |
| Metabolic disorders causing cirrhosis |
| Alpha-1-antitrypsin deficiency |
| Wilson disease |
| Nonalcoholic steatohepatitis and cryptogenic cirrhosis |
| Hereditary hemochromatosis |
| Tyrosinemia |
| Glycogen storage disease type IV |
| Metabolic disorders causing severe extrahepatic morbidity |
| Amyloidosis |
| Hyperoxaluria |
| Urea cycle defects |
| Disorders of branch chain amino acids |
| Miscellaneous conditions |
| Budd-Chiari syndrome |
| Metastatic neuroendocrine tumors |
| Polycystic disease |
| Biliary atresia |
| Alagille syndrome |
| Nonsyndromic paucity of the intrahepatic bile ducts |
| Cystic fibrosis |
| Progressive familial intrahepatic cholestasis |
Table 2 Contraindications to liver transplantation
| Absolute |
| Extrahepatic malignancy |
| Hepatic malignancy with macrovascular or diffuse tumor invasion |
| Active and uncontrolled infection outside of the hepatobiliary system |
| Active substance or alcohol abuse |
| Severe pulmonary hypertension uncontrolled with medical therapy |
| Obesity (BMI > 40 kg/m2) |
| Advanced cardiopulmonary disease |
| Psychosocial factors that would likely preclude recovery after |
| transplantation |
| Technical and/or anatomical barriers |
| Brain death |
| Acquired immune deficiency syndrome |
| Relative |
| Age |
| Cholangiocarcinoma |
| Portal vein thrombosis |
| Chronic or refractory infections |
| Human immunodeficiency virus infection |
| Previous malignancy |
| Active psychiatric illness |
| Poor social support |
Table 3 Main causes of acute liver failure
| Infective |
| Virus |
| Hepatotropic: HAV, HBV, HBV + HDV, HEV |
| Non-hepatotropic: Adenovirus, Epstein-Barr, Cytomegalovirus, |
| Echovirus, Varicella Zoster virus, Yellow fever, Herpes simplex , |
| Parvovirus B19, Coxsackie |
| Rarely virus: Lassa, Ebola, Marburg e Toga Virus |
| Bacteria: Salmonellosis, Tuberculosis, Septicemia |
| Others: Malaria, Bartonella, Leptospirosis |
| Drugs |
| Dose dependent: Paracetamol, Halothane |
| Idiosyncratic reactions: Isoniazid, Nonsteroidal anti-inflammatory |
| drugs, Phenytoin, Sodium valproate, Carbamazepine, Ecstasy, |
| Tioglitazone, Antibiotics, Allopurinol, Propylthiouracil, Amiodarone, |
| ketoconazole, Antiretroviral drugs |
| Synergistic drug interactions: |
| Isoniazid + Rifampicin |
| Trimethoprim + Sulfamethoxazole |
| Barbiturates + Paracetamol |
| Amoxycillin + Clavulanic Acid |
| Toxins |
| Amanita phalloides (mushroom poisoning), Herbal medicines, Carbon |
| tetrachloride, Yellow phosphorus, Industrial solvents, Chlorbenzenes |
| Metabolic disease |
| Galactosemia, Tyrosinemia, Hereditary fructose intolerance, Neonatal |
| hemochromatosis, Niemann-Pick disease type C, Wilson’s disease, |
| Mitochondrial cytopathies, Congenital disorder of glycosylation, |
| Acute fatty liver of pregnancy |
| Autoimmune hepatitis |
| Type 1 autoimmune hepatitis, Type 2 autoimmune hepatitis, Giant cell |
| hepatitis with Coomb’s positive hemolytic anemia |
| Vascular disease |
| Budd-Chiari syndrome, Acute circulatory failure, Heat stroke, |
| Acute cardiac failure, Cardiomyopathies |
| Oncology disease |
| Hemophagocytic lymphohistiocytosis, Leukemia, Lymphoma |
- Citation: Siciliano M, Parlati L, Maldarelli F, Rossi M, Ginanni Corradini S. Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther 2012; 3(4): 49-61
- URL: https://www.wjgnet.com/2150-5349/full/v3/i4/49.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v3.i4.49
